Episode 25
12mg for SVT | COACT at 5 Years
The JournalFeed podcast for the week of June 15-19, 2026.
These are summaries from just 2 of the 5 articles we cover every week! For access to more, please visit JournalFeed.org for details about becoming a member.
A starting dose of 12mg of adenosine for stable supraventricular tachycardia (SVT) resulted in higher initial successful cardioversion rates and persistence of sinus rhythm thereafter without increased adverse effects.
No significant survival benefit was identified in 5-year follow-up of patients randomized to immediate vs. delayed coronary angiography after out-of-hospital cardiac arrest (OHCA) survival without ST segment elevation.
